Pancreatic Cancer Research

ResearcherNational Cancer CenterActive in the last 2 years

Sung Jun Kim

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7876-7901; OpenAlex author ID A5083165659. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. ATR inhibition promotes synergistic antitumor effect in platinum-resistant pancreatic cancer. Co-author DOI 10.1016/j.bbadis.2024.167625↗
  2. Coacervate-mediated novel pancreatic cancer drug Aleuria Aurantia lectin delivery for augmented anticancer therapy. Co-author DOI 10.1186/s40824-022-00282-6↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kyobum Kim · 1 shared paper, 2022 · strength 0.26
  2. Hye Won Shon · 1 shared paper, 2025 · strength 0.20
  3. Yu‐Sun Lee · 1 shared paper, 2025 · strength 0.20
  4. Woo Hyun Paik · 1 shared paper, 2025 · strength 0.20
  5. In Rae Cho · 1 shared paper, 2025 · strength 0.20
  6. Jung Won Chun · 1 shared paper, 2025 · strength 0.20
  7. Sang Hyub Lee · 1 shared paper, 2025 · strength 0.20
  8. Ji Kon Ryu · 1 shared paper, 2025 · strength 0.20
  9. Woo Jin Lee · 1 shared paper, 2025 · strength 0.20
  10. Sun‐Young Kong · 1 shared paper, 2025 · strength 0.20
  11. Yun‐Hee Kim · 1 shared paper, 2025 · strength 0.20
  12. Yong‐Tae Kim · 1 shared paper, 2025 · strength 0.20
  13. Sang Myung Woo · 1 shared paper, 2025 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.